These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37415951)

  • 1. Aurora kinase A regulates cancer-associated RNA aberrant splicing in breast cancer.
    Li S; Qi Y; Yu J; Hao Y; Xu L; Ding X; Zhang M; Geng J
    Heliyon; 2023 Jul; 9(7):e17386. PubMed ID: 37415951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear Aurora kinase A switches m
    Li S; Qi Y; Yu J; Hao Y; He B; Zhang M; Dai Z; Jiang T; Li S; Huang F; Chen N; Wang J; Yang M; Liang D; An F; Zhao J; Fan W; Pan Y; Deng Z; Luo Y; Guo T; Peng F; Hou Z; Wang C; Zheng F; Xu L; Xu J; Wen Q; Jin B; Wang Y; Liu Q
    Signal Transduct Target Ther; 2022 Apr; 7(1):97. PubMed ID: 35361747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aurora Kinase A-YBX1 Synergy Fuels Aggressive Oncogenic Phenotypes and Chemoresistance in Castration-Resistant Prostate Cancer.
    Nikhil K; Raza A; Haymour HS; Flueckiger BV; Chu J; Shah K
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32178290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear Aurora kinase A triggers programmed death-ligand 1-mediated immune suppression by activating MYC transcription in triple-negative breast cancer.
    Sun S; Zhou W; Li X; Peng F; Yan M; Zhan Y; An F; Li X; Liu Y; Liu Q; Piao H
    Cancer Commun (Lond); 2021 Sep; 41(9):851-866. PubMed ID: 34251762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells.
    Zou Z; Yuan Z; Zhang Q; Long Z; Chen J; Tang Z; Zhu Y; Chen S; Xu J; Yan M; Wang J; Liu Q
    Autophagy; 2012 Dec; 8(12):1798-810. PubMed ID: 23026799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated SRPK1 lessens apoptosis in breast cancer cells through RBM4-regulated splicing events.
    Lin JC; Lin CY; Tarn WY; Li FY
    RNA; 2014 Oct; 20(10):1621-31. PubMed ID: 25140042
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Long Q; An X; Chen M; Wang N; Sui S; Li Y; Zhang C; Lee K; Wang X; Tian T; Pan Y; Qiu H; Xie F; Deng W; Zheng F; He L
    Front Oncol; 2020; 10():568015. PubMed ID: 33117697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The aurora kinase A regulates GSK-3beta in gastric cancer cells.
    Dar AA; Belkhiri A; El-Rifai W
    Oncogene; 2009 Feb; 28(6):866-75. PubMed ID: 19060929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer.
    Gomes-Filho SM; Dos Santos EO; Bertoldi ERM; Scalabrini LC; Heidrich V; Dazzani B; Levantini E; Reis EM; Bassères DS
    Cell Oncol (Dordr); 2020 Jun; 43(3):445-460. PubMed ID: 32193808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comprehensive Prognostic and Immune Infiltration Analysis of RBM4 in Pan-Cancer.
    Ding JJ; Wu J; Bian HL; Zong Y; Lu B; Ni L
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):89. PubMed ID: 38420804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RBM4 interacts with an intronic element and stimulates tau exon 10 inclusion.
    Kar A; Havlioglu N; Tarn WY; Wu JY
    J Biol Chem; 2006 Aug; 281(34):24479-88. PubMed ID: 16777844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype.
    Zheng F; Yue C; Li G; He B; Cheng W; Wang X; Yan M; Long Z; Qiu W; Yuan Z; Xu J; Liu B; Shi Q; Lam EW; Hung MC; Liu Q
    Nat Commun; 2016 Jan; 7():10180. PubMed ID: 26782714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer Nanovesicle-Mediated Delivery of MLN8237 Preferentially Inhibits Aurora Kinase A To Target RalA and Anchorage-Independent Growth in Breast Cancer Cells.
    Inchanalkar S; Deshpande NU; Kasherwal V; Jayakannan M; Balasubramanian N
    Mol Pharm; 2018 Aug; 15(8):3046-3059. PubMed ID: 29863884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells.
    Yang N; Wang C; Wang Z; Zona S; Lin SX; Wang X; Yan M; Zheng FM; Li SS; Xu B; Bella L; Yong JS; Lam EW; Liu Q
    Oncogene; 2017 Jun; 36(24):3428-3440. PubMed ID: 28114286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients.
    Siggelkow W; Boehm D; Gebhard S; Battista M; Sicking I; Lebrecht A; Solbach C; Hellwig B; Rahnenführer J; Koelbl H; Gehrmann M; Marchan R; Cadenas C; Hengstler JG; Schmidt M
    BMC Cancer; 2012 Nov; 12():562. PubMed ID: 23186136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural antisense transcript TPM1-AS regulates the alternative splicing of tropomyosin I through an interaction with RNA-binding motif protein 4.
    Huang GW; Zhang YL; Liao LD; Li EM; Xu LY
    Int J Biochem Cell Biol; 2017 Sep; 90():59-67. PubMed ID: 28754317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression.
    Wang Y; Chen D; Qian H; Tsai YS; Shao S; Liu Q; Dominguez D; Wang Z
    Cancer Cell; 2014 Sep; 26(3):374-389. PubMed ID: 25203323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Control of Cancer Cell Proliferation and Cell Cycle Progression by HNRNPK via Promoting Exon 4 Inclusion of Histone Code Reader SPIN1.
    Li D; Guo J; Jia R
    J Mol Biol; 2023 Mar; 435(6):167993. PubMed ID: 36736887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RBM4 down-regulates PTB and antagonizes its activity in muscle cell-specific alternative splicing.
    Lin JC; Tarn WY
    J Cell Biol; 2011 May; 193(3):509-20. PubMed ID: 21518792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aurora Kinase A Is an Independent Predictor of Invasive Recurrence in Breast Ductal Carcinoma in situ.
    Miligy IM; Toss MS; Gorringe KL; Ellis IO; Green AR; Rakha EA
    Pathobiology; 2022; 89(6):382-392. PubMed ID: 35533650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.